Jensen Investment Management Trimmed Hillenbrand (HI) Position By $300,810; Aveo Pharmaceuticals (AVEO)’s Sentiment Is 1.29

Hillenbrand, Inc. (NYSE:HI) Logo

Jensen Investment Management Inc decreased Hillenbrand Inc. (HI) stake by 41.59% reported in 2018Q4 SEC filing. Jensen Investment Management Inc sold 8,130 shares as Hillenbrand Inc. (HI)’s stock declined 1.08%. The Jensen Investment Management Inc holds 11,420 shares with $433,000 value, down from 19,550 last quarter. Hillenbrand Inc. now has $2.70 billion valuation. The stock decreased 0.46% or $0.2 during the last trading session, reaching $43.1. About 1.09 million shares traded or 255.29% up from the average. Hillenbrand, Inc. (NYSE:HI) has risen 0.32% since March 17, 2018 and is uptrending. It has underperformed by 4.05% the S&P500. Some Historical HI News: 14/05/2018 – Hillenbrand Bd Elects Daniel C. Hillenbrand Independent Director; 10/05/2018 – Hillenbrand Declares Third Quarter Dividend of $0.2075 Per Share; 14/05/2018 – HILLENBRAND NAMES DANIEL C. HILLENBRAND INDEPENDENT DIRECTOR; 23/03/2018 – Hillenbrand Closes Below 50-Day Moving Average: Technicals; 02/05/2018 – HILLENBRAND RAISING ADJUSTED EPS GUIDANCE FOR 2018; 30/03/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within Hillenbrand, Synnex, CoreSite Realty, Orchids Paper Product; 09/03/2018 – HILLENBRAND SAYS ON MARCH 8, CO, UNITS ENTERED INTO A SYNDICATED L/G FACILITY AGREEMENT – SEC FILING; 02/05/2018 – HILLENBRAND 2Q ADJ EPS 65C, EST. 64C; 14/05/2018 – Hillenbrand Board Elects Daniel C. Hillenbrand Independent Director; 09/03/2018 HILLENBRAND IN SYNDICATED L/G FACILITY PACT

Aveo Pharmaceuticals Inc (AVEO) investors sentiment decreased to 1.29 in Q4 2018. It’s down -0.24, from 1.53 in 2018Q3. The ratio worsened, as 45 investment professionals opened new and increased stock positions, while 35 decreased and sold holdings in Aveo Pharmaceuticals Inc. The investment professionals in our database reported: 48.91 million shares, down from 49.71 million shares in 2018Q3. Also, the number of investment professionals holding Aveo Pharmaceuticals Inc in top ten stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 17 Reduced: 18 Increased: 27 New Position: 18.

Nea Management Company Llc holds 1.33% of its portfolio in AVEO Pharmaceuticals, Inc. for 20.90 million shares. Granahan Investment Management Inc Ma owns 2.51 million shares or 0.28% of their US portfolio. Moreover, 683 Capital Management Llc has 0.18% invested in the company for 1.88 million shares. The New York-based New Leaf Venture Partners L.L.C. has invested 0.18% in the stock. Evercore Wealth Management Llc, a New York-based fund reported 418,414 shares.

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for cancer and related diseases. The company has market cap of $73.97 million. The companyÂ’s pipeline of product candidates include Tivozanib, a vascular endothelial growth factor to optimize VEGF blockade; Ficlatuzumab, a hepatocyte growth factor (HGF) inhibitory antibody, which has completed Phase II trial that inhibits the activity of the HGF/c-Met pathway; and AV-203, an anti-ErbB3 specific monoclonal antibody that has completed a Phase I dose escalation study. It currently has negative earnings. The Company’s development programs also comprise AV-380, a humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; and the AV-353 platform for the potential treatment of pulmonary arterial hypertension.

The stock decreased 0.99% or $0.0059 during the last trading session, reaching $0.5901. About 3.51 million shares traded. AVEO Pharmaceuticals, Inc. (AVEO) has declined 80.40% since March 17, 2018 and is downtrending. It has underperformed by 84.77% the S&P500. Some Historical AVEO News: 09/04/2018 – Aveo at HC Wainwright Global Biotechnology Conference Tomorrow; 08/05/2018 – AVEO Pharmaceuticals 1Q Rev $1.03M; 13/04/2018 – CHINA MEDICAL & HEALTHCARE GROUP LTD 0383.HK – UNIT TO BUY 30 PCT STAKE IN AVEO CHINA (HOLDINGS) FOR HK$87.3 MLN; 17/04/2018 – Aveo Company Marketing Set By B. Riley FBR, Inc. for Apr. 24; 10/05/2018 – Sphera Funds Management Exits Position in Aveo; 21/03/2018 – AVEO Oncology Announces Publication of Long-term Follow-up Results from TIVO-1 Extension Study (Study 902) in TKI Refractory; 13/03/2018 – AVEO PHARMACEUTICALS INC QUARTERLY SHR LOSS $0.08; 13/03/2018 – AVEO Reports Full Year 2017 Financial Results and Provides Business Update; 21/05/2018 – Fintel Insider Buying Report: ZAIS Group Holdings, Inc. (ZAIS), AVEO Pharmaceuticals, Inc. (AVEO), And Others; 21/03/2018 – Aveo Closes Above 50-Day Moving Average: Technicals

More notable recent AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) news were published by: which released: “AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat, Revenues Lag – Nasdaq” on March 15, 2019, also with their article: “AVEO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEO – GlobeNewswire” published on March 16, 2019, published: “AVEO: A Speculative Buy – Seeking Alpha” on March 04, 2019. More interesting news about AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) were released by: and their article: “AVEO DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against AVEO Pharmaceuticals Inc.– AVEO – GlobeNewswire” published on March 12, 2019 as well as‘s news article titled: “(AVEO) AVEO Pharmaceuticals, Inc. Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Final Deadline: April 26, 2019 – GlobeNewswire” with publication date: March 08, 2019.

Since January 1, 0001, it had 57 buys, and 1 insider sale for $36.43 million activity.

More notable recent Hillenbrand, Inc. (NYSE:HI) news were published by: which released: “Hi-Crush Partners LP Files 2018 10-K NYSE:HCLP – GlobeNewswire” on February 19, 2019, also with their article: “Hi-Crush Partners LP Announces Availability of Schedule K-1s – GlobeNewswire” published on March 08, 2019, published: “Hi-Crush Partners LP to Participate in Scotia Howard Weil Energy Conference – GlobeNewswire” on March 13, 2019. More interesting news about Hillenbrand, Inc. (NYSE:HI) were released by: and their article: “Southwest Airlines Is 1 Step Closer to Hawaii Flights – The Motley Fool” published on February 17, 2019 as well as‘s news article titled: “Southwest Airlines Launches Hawaii Flights With a Huge Sale – The Motley Fool” with publication date: March 04, 2019.

Investors sentiment increased to 1.02 in 2018 Q4. Its up 0.07, from 0.95 in 2018Q3. It increased, as 36 investors sold HI shares while 70 reduced holdings. 37 funds opened positions while 71 raised stakes. 47.97 million shares or 4.04% more from 46.11 million shares in 2018Q3 were reported. Ameriprise Fincl holds 0.01% or 486,935 shares. Gateway Inv Advisers Lc accumulated 21,850 shares. Fifth Third Bankshares owns 141,724 shares for 0.04% of their portfolio. 9,818 are owned by Johnson Counsel. Bahl & Gaynor has invested 0.01% in Hillenbrand, Inc. (NYSE:HI). Financial Counselors invested in 95,334 shares or 0.18% of the stock. Federated Inc Pa has 0% invested in Hillenbrand, Inc. (NYSE:HI) for 1,342 shares. Wellington Gp Llp invested in 0% or 18,926 shares. Smart Portfolios Llc holds 0% or 143 shares in its portfolio. Fort LP accumulated 33,496 shares or 0.3% of the stock. Employees Retirement Association Of Colorado stated it has 11,435 shares or 0% of all its holdings. United Serv Automobile Association has invested 0% in Hillenbrand, Inc. (NYSE:HI). Mutual Of America Cap Ltd Llc has 1,552 shares. Bernzott Capital Advsrs accumulated 500,560 shares. Shell Asset Mgmt has invested 0.02% in Hillenbrand, Inc. (NYSE:HI).

Jensen Investment Management Inc increased Microsoft Corp (NASDAQ:MSFT) stake by 10,185 shares to 4.12 million valued at $418.74 million in 2018Q4. It also upped Apple Inc. (NASDAQ:AAPL) stake by 116,460 shares and now owns 1.38 million shares. Alphabet Inc Cap Stk Cl A was raised too.

Hillenbrand, Inc. (NYSE:HI) Institutional Positions Chart